Chinese medicines for prevention and treatment of human hepatocellular carcinoma: Current progress on pharmacological actions and mechanisms

Journal of Integrative Medicine

Volumn 13, Issue 3, 2015, Pages 142-164

  Wang, Xuanbin ^a,b   Wang, Ning ^a   Cheung, Fan ^a   Lao, Lixing ^a   Li, Charlie ^c   Feng, Yibin ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

^c CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

disease treating preventing; hepatocellular carcinoma; liver neoplasms; medicine, Chinese traditional; molecular targets; recurrence; review

Indexed keywords

ANTINEOPLASTIC AGENT; HERBACEOUS AGENT; PLANT EXTRACT; NFE2L2 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2;

ANTINEOPLASTIC ACTIVITY; CANCER PREVENTION; CANCER RESISTANCE; CANCER STEM CELL; CANCER THERAPY; CHINESE HERB; CHINESE MEDICINE; LIVER CELL CARCINOMA; METASTASIS INHIBITION; OXIDATIVE STRESS; REVIEW; CARCINOMA, HEPATOCELLULAR; DRUG EFFECTS; HUMAN; LIVER NEOPLASMS; METABOLISM; MULTIDRUG RESISTANCE; PHYSIOLOGY;

CARCINOMA, HEPATOCELLULAR; DRUG RESISTANCE, MULTIPLE; HUMANS; LIVER NEOPLASMS; MEDICINE, CHINESE TRADITIONAL; NEOPLASTIC STEM CELLS; NF-E2-RELATED FACTOR 2; REACTIVE OXYGEN SPECIES;

EID: 85050578557     PISSN: 20954964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2095-4964(15)60171-6     Document Type: Review

References (217)

1. A Jemal, F Bray, MM Center, J Ferlay, E Ward, D Forman Global cancer statistics Ca Cancer J Clin 61 2 2011 69 90
2. CY Pu, VM Lan, CF Lan, HC Lang The determinants of traditional Chinese medicine and acupuncture utilization for cancer patients with simultaneous conventional treatment Eur J Cancer Care (Engl) 17 4 2008 340 349
3. YH Lin, JH Chiu Use of Chinese medicine among patients with liver cancer in Taiwan J Altern Complem Med 16 5 2010 527 528
4. B Carmady, CA Smith Use of Chinese medicine by cancer patients: a review of surveys Chin Med 6 2011 22
5. LC Wong, E Chan, S Tay, KM Lee, M Back Complementary and alternative medicine practices among Asian radiotherapy patients Asia Pac J Clin Oncol 6 4 2010 357 363
6. M Pan, B Pan Review and expectation of experiments and clinical study in primary liver cancer Hunan Zhong Yi Za Zhi 18 4 2002 1 3 Chinese.
7. Y Liu, C Xu, YZ Zhang An analysis on the international competitiveness of China's traditional medicine industry based on the SWOT model Int J Bus Man 5 7 2010 225 229
8. J Hou, D Wang, R Zhang, H Wang Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action Clin Cancer Res 14 17 2008 5519 5530
9. W Chaijaroenkul, V Viyanant, W Mahavorasirikul, K Na-Bangchang Cytotoxic activity of artemisinin derivatives against cholangiocarcinoma (CL-6) and hepatocarcinoma (Hep-G2) cell lines Asia Pac J Cancer Prev 12 1 2011 55 59
10. WQ Wang, L Liu, HC Sun, YL Fu, HX Xu, ZT Chai, QB Zhang, LQ Kong, XD Zhu, L Lu, ZG Ren, ZY Tang Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization J Hematol Oncol 5 2012 69
11. X Yuxian, T Feng, L Ren, L Zhengcai Tanshinone II-A inhibits invasion and metastasis of human hepatocellular carcinoma cells in vitro and in vivo Tumori 95 6 2009 789 795
12. Y Wang, Q Li, ZZ Fan, J Sun, YQ Wang, RH Liu, H Gao Tanshinone II-A induces apoptosis of liver cancer cells via p38MAPK signal transduction Shi Jie Hua Ren Xiao Hua Za Zhi 17 2 2009 124 129 Chinese with abstract in English.
13. SY Chien, SJ Kuo, YL Chen, DR Chen, CY Cheng, CC Su Tanshinone II-A inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo Mol Med Report 5 1 2012 282 286
14. ZK Dai, JK Qin, JE Huang, Y Luo, Q Xu, HL Zhao Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells J Nat Med 66 1 2012 192 201
15. JM Luk, X Wang, P Liu, KF Wong, KL Chan, Y Tong, CK Hui, GK Lau, ST Fan Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation Liver Int 27 7 2007 879 890
16. BE Wang Treatment of chronic liver diseases with traditional Chinese medicine J Gastroenterol Hepatol 15 S2 2000 E67 E70
17. 4-induced hepatic fibrosis through regulating NF-κB/IκBα signaling J Ethnopharmacol 144 3 2012 592 598
18. VK Wong, P Chiu, SS Chung, LM Chow, YZ Zhao, BB Yang, BC Ko Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo Clin Cancer Res 11 16 2005 6002 6011
19. WY Wu, HZ Guo, GQ Qu, J Han, DA Guo Mechanisms of pseudolaric acid B-induced apoptosis in Bel-7402 cell lines Am J Chin Med 34 5 2006 887 899
20. L Yang, X Liu, Z Lu, J Yuet-Wa Chan, L Zhou, KP Fung, P Wu, S Wu Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor Cancer Lett 298 1 2010 128 138
21. BJ Chen Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F Leuk Lymphoma 42 3 2001 253 265
22. EW Chan, SC Cheng, FW Sin, Y Xie Triptolide induced cytotoxic effects on human promyelocytic leukemia, T cell lymphoma and human hepatocellular carcinoma cell lines Toxicol Lett 122 1 2001 81 87
23. G Chen, K Wang, BY Yang, B Tang, JX Chen, ZC Hua Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells Int J Oncol 40 1 2012 139 147
24. H Wang, Y Ye, SY Pan, GY Zhu, YW Li, DW Fong, ZL Yu Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells Phytomedicine 18 2-3 2011 163 169
25. C Duan, J Gao, D Zhang, L Jia, Y Liu, D Zheng, G Liu, X Tian, F Wang, Q Zhang Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin Biomacromolecules 12 12 2011 4335 4343
26. SS Dang, XL Jia, P Song, YA Cheng, X Zhang, MZ Sun, EQ Liu Inhibitory effect of emodin and Astragalus polysaccharide on the replication of HBV World J Gastroenterol 15 45 2009 5669 5673
27. ZF Chen, MX Tan, YC Liu, Y Peng, HH Wang, HG Liu, H Liang Synthesis, characterization and preliminary cytotoxicity evaluation of five lanthanide(III)-plumbagin complexes J Inorg Biochem 105 3 2011 426 434
28. YW Hu, CY Liu, CM Du, J Zhang, WQ Wu, ZL Gu Induction of apoptosis in human hepatocarcinoma SMMC-7721 cells in vitro by flavonoids from Astragalus complanatus J Ethnopharmacol 123 2 2009 293 301
29. XL Zeng, ZG Tu Induction of differentiation by ginsenoside Rh2 in hepatocarcinoma cell SMMC-7721 Ai Zheng 23 8 2004 879 884 Chinese with abstract in English.
30. XL Zeng, ZG Tu Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721 Ai Zheng 23 12 2004 1655 1659 Chinese with abstract in English.
31. HM Park, SJ Kim, JS Kim, HS Kang Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways Food Chem Toxicol 50 8 2012 2736 2741
32. C Rui-Chuan, S Jin-Hua, O Gao-Liang, C Ke-Xia, L Jin-Quan, X Xiao-Guang Induction of differentiation in human hepatocarcinoma cells by isoverbascoside Planta Med 68 4 2002 370 372
33. RKY Lee, RCY Ong, JYN Cheung, YC Li, JYW Chan, MMS Lee, YK Suen, KP Fung, HP Ho, B Yu, M Li, TT Kwok, SK Kong Polyphyllin D - A potential anti-cancer agent to kill hepatocarcinoma cells with multi-drug resistance Current Chemic Biol 3 1 2009 89 99
34. QF Wang, CW Chiang, CC Wu, CC Cheng, SJ Hsieh, JC Chen, YC Hsieh, SL Hsu Gypenosides induce apoptosis in human hepatoma Huh-7 cells through a calcium/reactive oxygen species-dependent mitochondrial pathway Planta Med 73 6 2007 535 544
35. Y Guo, J Yao, J Wu The effect of baicalin on apoptosis, invasion and metastasis of human hepatocellular line BEL-7402 in vitro and its molecular basis Zhong Yao Yao Li Yu Lin Chuang 24 4 2008 15 18 Chinese.
36. Y Guo, SK Yao Effect of baicalin on invasion and metastasis of human hepatocellular line BEL-7402 in vitro Di San Jun Yi Da Xue Xue Bao 28 6 2006 594 597 Chinese with abstract in English.
37. MH Yeh, ST Kao, CM Hung, CJ Liu, KH Lee, CC Yeh Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells Toxicol Lett 184 3 2009 204 210
38. L Shi, C Tang, C Yin Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma Biomaterials 33 30 2012 7594 7604
39. TR Morgan Chemoprevention of hepatocellular carcinoma in chronic hepatitis C Recent Results Cancer Res 188 2011 85 99
40. T Wakamatsu, Y Nakahashi, D Hachimine, T Seki, K Okazaki The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins Int J Oncol 31 6 2007 1465 1472
41. TY Wu, TO Khor, CL Saw, SC Loh, AI Chen, SS Lim, JH Park, L Cai, AN Kong Anti-inflammatory/anti-oxidative stress activities and differential regulation of Nrf2-mediated genes by non-polar fractions of tea Chrysanthemum zawadskii and licorice Glycyrrhiza uralensis Glycyrrhiza uralensis 13 1 2011 1 13
42. LB Seeff, KL Lindsay, BR Bacon, TF Kresina, JH Hoofnagle Complementary and alternative medicine in chronic liver disease Hepatology 34 3 2001 595 603
43. L Lou, W Ye, Y Chen, S Wu, L Jin, J He, X Tao, J Zhu, X Chen, A Deng, J Wang Ardipusilloside inhibits survival, invasion and metastasis of human hepatocellular carcinoma cells Phytomedicine 19 7 2012 603 608
44. 2 cells toward the cytotoxicity of cisplatin by the treatment of piper betel leaf extract Arch Toxicol 80 6 2006 319 327
45. C Chen, R Yu, ED Owuor, ANT Kong Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death Arch Pharm Res 23 6 2000 605 612
46. T Eichhorn, T Efferth P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs J Ethnopharmacol 141 2 2012 557 570
47. L He, C Zhao, M Yan, LY Zhang, YZ Xia Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier Phytother Res 23 7 2009 933 937
48. CY Yang, PD Chao, YC Hou, SY Tsai, KC Wen, SL Hsiu Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats Food Chem Toxicol 44 9 2006 1572 1578
49. Q Du, B Hu, HM An, KP Shen, L Xu, S Deng, MM Wei Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells Oncol Rep 29 5 2013 1851 1858
50. H Hatcher, R Planalp, J Cho, FM Torti, SV Torti Curcumin: from ancient medicine to current clinical trials Cell Mol Life Sci 65 11 2008 1631 1652
51. M Iqbal, SD Sharma, Y Okazaki, M Fujisawa, S Okada Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity Pharmacol Toxicol 92 1 2003 33 38
52. G Kaur, N Tirkey, S Bharrhan, V Chanana, P Rishi, K Chopra Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents Clin Exp Immunol 145 2 2006 313 321
53. M López-Lázaro Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent Mol Nutr Food Res 52 Suppl 1 2008 S103 S127
54. H Manjunatha, K Srinivasan Protective effect of dietary curcumin and capsaicin on induced oxidation of low-density lipoprotein, iron-induced hepatotoxicity and carrageenan-induced inflammation in experimental rats FEBS J 273 19 2006 4528 4537
55. K Reyes-Gordillo, J Segovia, M Shibayama, P Vergara, MG Moreno, P Muriel Curcumin protects against acute liver damage in the rat by inhibiting NF-κB, proinflammatory cytokines production and oxidative stress Biochim Biophys Acta 1770 6 2007 989 996
56. RG Fan, XX Shan, CZ Song, JP Zhou, YC Qiu Apoptosis induced by emodin in human hepatoma cell line Smmc-7721 in vitro Hebei Yi Xue 14 11 2008 1264 1270 Chinese with abstract in English.
57. X Jing, N Ueki, J Cheng, H Imanishi, T Hada Induction of apoptosis in hepatocellular carcinoma cell lines by emodin Jpn J Cancer Res 93 8 2002 874 882
58. JJ Lah, W Cui, KQ Hu Effects and mechanisms of silibinin on human hepatoma cell lines World J Gastroenterol 13 40 2007 5299 5305
59. MJ Ren, GQ Zuo, S He Effect of silibinin on proliferation of human hepatocellular carcinoma HepG2 in vitro and relevant mechanisms Chongqing Yi Xue 34 3 2005 369 372 Chinese with abstract in English.
60. X Wang, Y Chen, QB Han, CY Chan, H Wang, Z Liu, CH Cheng, DT Yew, MC Lin, ML He, HX Xu, JJ Sung, HF Kung Proteomic identification of molecular targets of gambogic acid: role of stathmin in hepatocellular carcinoma Proteomics 9 2 2009 242 253
61. QL Guo, SS Lin, QD You, HY Gu, J Yu, L Zhao, Q Qi, F Liang, Z Tan, X Wang Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells Life Sci 78 11 2006 1238 1245
62. QL Guo, QD You, ZQ Wu, ST Yuan, L Zhao General gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude mice Acta Pharmacol Sin 25 6 2004 769 774
63. Y Yang, L Yang, QD You, FF Nie, HY Gu, L Zhao, XT Wang, QL Guo Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes Cancer Lett 256 2 2007 259 266
64. YC Chen, SC Shen, WR Lee, HY Lin, CH Ko, CM Shih, LL Yang Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1 Arch Toxicol 76 5-6 2002 351 359
65. W Wang, Q Guo, Q You, K Zhang, Y Yang, J Yu, W Liu, L Zhao, H Gu, Y Hu, Z Tan, X Wang Involvement of bax/bcl-2 in wogonin-induced apoptosis of human hepatoma cell line SMMC-7721 Anticancer Drugs 17 7 2006 797 805
66. Y Hu, Y Yang, QD You, W Liu, HY Gu, L Zhao, K Zhang, W Wang, XT Wang, QL Guo Oroxylin A induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity Biochem Biophys Res Commun 351 2 2006 521 527
67. ZJ Dai, WY Wu, HF Kang, XB Ma, SQ Zhang, WL Min, WF Kang, XB Ma, SQ Zhang, WL Min, WF Lu, S Lin, XJ Wang Protective effects of Scutellaria barbata against rat liver tumorigenesis Asian Pac J Cancer Prev 14 1 2013 261 265
68. ZJ Dai, BF Wang, WF Lu, ZD Wang, XB Ma, WL Min, HF Kang, XJ Wang, WY Wu Total flavonoids of Scutellaria barbata inhibit invasion of hepatocarcinoma via MMP/TIMP in vitro Molecules 18 1 2013 934 950
69. MY Sun, J Zuo, JF Duan, J Han, SM Fan, W Zhang, LF Zhu, MH Yao Antitumor activities of Kushen flavonoids in vivo and in vitro J Chin Integr Med 6 1 2008 51 59 Chinese with abstract in English.
70. JQ Zhang, YM Li, T Liu, WT He, YT Chen, XH Chen, X Li, WC Zhou, JF Yi, ZJ Ren Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy World J Gastroenterol 16 34 2010 4281 4290
71. D Guo, NN Chen, P Zhou, B Pan, LB Hou Suppressive effect of matrine on cell growth and β-catenin-dependent transcriptional activity in hepatoma cell line Hep3B Zhong Yao Cai 33 5 2010 778 781 Chinese with abstract in English.
72. YW Guo, XQ Wei, YW Li, FP Zheng, SJ Yang Effects of matrine, 5-fluorouracil and cisplatin on the expression of APRIL in hepatocellular carcinoma HepG2 cells Zhonghua Gan Zang Bing Za Zhi 16 7 2008 532 533 Chinese.
73. H Gao, S He, WX Tang, J Wang Inhibition of NF-κB activity enhanced apoptosis induced by matrine in hepatocellular carcinoma cells Zhonghua Gan Zang Bing Za Zhi 15 12 2007 914 917 Chinese with abstract in English.
74. LD Ma, Y Zhang, SH Wen, YJ He, XS Liu, GF Kang, JK Jiang Inhibition of tumor growth in tumor-bearing mice treated with matrine Zhonghua Zhong Liu Za Zhi 27 6 2005 339 341 Chinese with abstract in English.
75. XS Chen, GJ Wang, X Cai, HY Yu, YP Hu Inhibition of hepatitis B virus by oxymatrine in vivo J Chin Integr Med 7 1 2001 49 52
76. G Song, Q Luo, J Qin, L Wang, Y Shi, C Sun Effects of oxymatrine on proliferation and apoptosis in human hepatoma cells Colloids Surf B Biointerfaces 48 1 2006 1 5
77. Z Lin, CF Huang, XS Liu, J Jiang In vitro anti-tumour activities of quinolizidine alkaloids derived from Sophora flavescens Ait Basic Clin Pharmacol Toxicol 108 5 2011 304 309
78. KK Auyeung, JK Ko Coptis chinensis inhibits hepatocellular carcinoma cell growth through nonsteroidal anti-inflammatory drug-activated gene activation Int J Mol Med 24 4 2009 571 577
79. JM Hur, MS Hyun, SY Lim, WY Lee, D Kim The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells J Cell Biochem 107 5 2009 955 964
80. Q Hou, X Tang, H Liu, J Tang, Y Yang, X Jing, Q Xiao, W Wang, X Gou, Z Wang Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147 Cancer Sci 102 7 2011 1287 1292
81. JM Hwang, HC Kuo, TH Tseng, JY Liu, CY Chu Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells Arch Toxicol 80 2 2006 62 73
82. S Jie, H Li, Y Tian, D Guo, J Zhu, S Gao, L Jiang Berberine inhibits angiogenic potential of HepG2 cell line through VEGF down-regulation in vitro J Gastroenterol Hepatol 26 1 2011 179 185
83. J Tang, Y Feng, S Tsao, N Wang, R Curtain, Y Wang Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations J Ethnopharmacol 126 1 2009 5 17
84. 2 arrest and apoptosis at high doses in human cancer cells Int J Mol Med 24 1 2009 131 138
85. N Wang, Y Feng, M Zhu, CM Tsang, K Man, Y Tong, SW Tsao Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism J Cell Biochem 111 6 2010 1426 1436
86. X Zhang, Y Zhou, B Xu Differentiation of human hepatoma HepG2 cells induced by 10-hydroxycamptothecin Chin Med J (Engl) 113 8 2000 712 713
87. XW Zhang, JF Jiang, B Xu Differentiation-inducing action of 10-hydroxycamptothecin on human hepatoma HepG2 cells Acta Pharmacol Sin 21 4 2000 364 368
88. Z Cheng, K Wang, J Wei, X Lu, B Liu Proteomic analysis of anti-tumor effects by tetrandrine treatment in HepG2 cells Phytomedicine 17 13 2010 1000 1005
89. WY Deng, SX Luo, MQ Zhou, N Li, XB Chen, LL Han The study of anti-tumor effect of tetrandrine combined with nedaplatin on human liver cancer cell line 7402 Zhong Yao Cai 31 10 2008 1522 1525 Chinese with abstract in English.
90. C Liu, K Gong, X Mao, W Li Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma Int J Cancer 129 6 2011 1519 1531
91. CL Dai, HY Xiong, LF Tang, X Zhang, YJ Liang, MS Zeng, LM Chen, XH Wang, LW Fu Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent eVect on doxorubicin pharmacokinetics in mice Cancer Chemother Pharmacol 60 5 2007 741 750
92. Y Mei, YJ Shi, GQ Zuo, JP Gong, CA Liu, XH Li, MJ Ren Study on ligustrazine in reversing multidrug resistance of HepG2/ADM cell in vitro Zhongguo Zhong Yao Za Zhi 29 10 2004 970 973 Chinese with abstract in English.
93. XB Wang, SS Wang, QF Zhang, M Liu, HL Li, Y Liu, JN Wang, F Zheng, LY Guo, JZ Xiang Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells Oncol Rep 23 1 2010 211 215
94. J Yu, BK Piao, YX Pei, X Qi, BJ Hua Protective effects of tetrahydropalmatine against γ-radiation induced damage to human endothelial cells Life Sci 87 1-2 2010 55 63
95. T Yamazaki, T Tokiwa Isofraxidin, a coumarin component from Acanthopanax senticosus, inhibits matrix metalloproteinase-7 expression and cell invasion of human hepatoma cells Bio Pharm Bull 33 10 2010 1716 1722
96. D Hu, Q Liu, H Cui, H Wang, D Han, H Xu Effects of amino acids from selenium-rich silkworm pupas on human hepatoma cells Life Sci 77 17 2005 2098 2110
97. CC Song, X Lu, BB Cheng, J DU, B Li, CQ Ling Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice Ai Zheng 26 12 2007 1315 1322 Chinese with abstract in English.
98. EF Fang, CZ Zhang, JH Wong, JY Shen, CH Li, TB Ng The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo Cancer Lett 324 1 2012 66 74
99. EM Beauchamp, L Ringer, G Bulut, KP Sajwan, MD Hall, YC Lee, D Peaceman, M Özdemirli, O Rodriguez, TJ Macdonald, C Albanese, JA Toretsky, A Üren Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway J Clin Invest 121 1 2011 148 160
100. L Luo, H Qiao, F Meng, X Dong, B Zhou, H Jiang, JR Kanwar, GW Krissansen, X Sun Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas Int J Cancer 118 7 2006 1823 1830
101. XS Zhao, PL Song, B Sun, HC Jiang, TF Liu Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo Hepatobiliary Pancreat Dis Int 8 5 2009 510 517
102. M Fei, M Lu, Y Wang, Y Zhao, S He, S Gao, Q Ke, Y Liu, P Li, X Cui, A Shen, C Cheng Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization Med Oncol 26 2 2009 178 185
103. HY Li, JN He, PX Ju, XP Zhong, JG Liu Studies on the mechanism of arsenic trioxide-induced apoptosis in HepG2 human hepatocellular carcinoma cells Chin J Clin Oncol 5 1 2008 22 25
104. X Cui, T Wakai, Y Shirai, N Yokoyama, K Hatakeyama, S Hirano Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells Hum Pathol 37 3 2006 298 311
105. DR Yoo, SA Chong, MJ Nam Proteome profiling of arsenic trioxide-treated human hepatic cancer cells Cancer Genomics Proteomics 6 5 2009 269 274
106. CC Lin, C Hsu, CH Hsu, WL Hsu, AL Cheng, CH Yang Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial Invest New Drugs 25 1 2006 77 84
107. YQ Gong, Y Fan, DZ Wu, H Yang, ZB Hu, ZT Wang In vivo and in vitro evaluation of erianin, a novel anti-angiogenic agent Eur J Cancer 40 10 2004 1554 1565
108. XF Zhu, BF Xie, JM Zhou, GK Feng, ZC Liu, XY Wei, FX Zhang, MF Liu, YX Zeng Blockade of vascular endothelial growth factor receptor signal pathway and antitumor activity of ON-III (2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone), a component from Chinese herbal medicine Mol Pharmacol 67 5 2005 1444 1450
109. D Huang, W Zhang, D Huang, J Wu Antitumor activity of the aqueous extract from Sedum sarmentosum Bunge in vitro Cancer Biother Radiopharm 25 1 2010 81 88
110. DZ Qiu, ZJ Zhang, WZ Wu, YK Yang Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells BMC Complement Altern Med 13 2013 185
111. C Wang, W Tan, X Huang, T Fu, J Lin, J Bu, G Wei, Y Du Curative effect of Dingqi analgesic patch on cancer pain: a single-blind randomized controlled trail J Tradit Chin Med 33 2 2013 176 180
112. DM Zhang, JS Liu, LJ Deng, MF Chen, A Yiu, HH Cao, HY Tian, KP Fung, H Kurihara, JX Pan, WC Ye Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway Carcinogenesis 34 6 2013 1331 1342
113. J Zhao, X Chen, W Lin, G Wu, Q Zhuang, X Zhong, Z Hong, J Peng Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis Int J Oncol 42 3 2013 971 978
114. 2/M cell cycle arrest and promoting apoptosis Eur J Pharmacol 698 1-3 2013 95 102
115. M Zhu, N Wang, SW Tsao, MF Yuen, Y Feng, TS Wan, K Man, Y Feng Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract Exp Ther Med 2 1 2011 27 32
116. N Wang, Y Feng, EP Lau, C Tsang, Y Ching, K Man, Y Tong, T Nagamatsu, W Su, S Tsao F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis Rhizoma on hepatoma cell migration Integr Cancer Ther 9 4 2010 354 364
117. XN Wang, X Han, LN Xu, LH Yin, YW Xu, Y Qi, JY Peng Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine Phytomedicine 15 12 2008 1062 1068
118. CQ Ling, Q Liu, DT Li, XQ Yue, FG Hou, DZ Zhu, CQ Yu, Z Chen, XF Zhai, Y Yu Study of a qualitative diagnostic criterion for basic syndromes of traditional Chinese medicine in patients with primary liver cancer J Chin Integr Med 3 2 2005 95 98 Chinese with abstract in English.
119. T Lu, G Zhao Advances in mechanisms of Xiao Chaihu Tang preventing and treating liver diseases Shi Jie Hua Ren Xiao Hua Za Zhi 16 9 2008 971 974 Chinese with abstract in English.
120. SJ Wang, Q Ai Mechanisms of Xiao-chai-hu-tang (Sho-saiko-to) on liver fibrosis and cancer Ri Ben Yi Xue Jie Shao 25 1 2004 42 44 Chinese.
121. JS Ding, JS Yang Fuzheng Xiaozheng capsules increase amount of white cells in 116 patients undergoing radiation and/or chemotherapy Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi 9 11 2003 38 39 Chinese.
122. H Zhang, XF Liu, ZH Zhao, RL Ding, BS Wang, CY Li Effect of Shuganjianpi therapy on immunologic function after transcatheter arterial chemoembolization in liver cancer patients Lin Chuang Jun Yi Za Zhi 35 6 2007 857 859 Chinese with abstract in English.
123. XS Fang, P Zhou Clinical efficacy of astragalus polysaccharide injection in treatment of primary live cancer patients Chongqing Yi Xue 38 8 2009 935 936 Chinese with abstract in English.
124. CC Chou, SL Pan, CM Teng, JH Guh Pharmacological evaluation of several major ingredients of Chinese herbal medicines in human hepatoma Hep3B cells Eur J Pharm Sci 19 5 2003 403 412
125. MJ Ren, GQ Zuo Effect of silibinin on proliferation of human hepatocellular carcinoma cell line SMMC-7721 in vitro Xian Dai Zhong Liu Xue 15 9 2007 1229 1231 Chinese with abstract in English.
126. YL Hsu, PL Kuo, TF Tzeng, SC Sung, MH Yen, LT Lin, CC Lin Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo J Gastroenterol Hepatol 23 7 Pt 2 2008 e290 e299
127. I Shimizu Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma J Gastroenterol Hepatol 15 Suppl 2000 D84 D90
128. AT Borchers, S Sakai, GL Henderson, MR Harkey, CL Keen, JS Stern, K Terasawa, ME Gershwin Shosaiko-to and other Kampo (Janpanese herbal) medicines: a review of their immunomodulatory activities J Ethnopharmacol 73 1-2 2000 1 13
129. JS Chang, KC Wang, HW Liu, MC Chen, LC Chiang, CC Lin Sho-saiko-to (Xiao-Chai-Hu-Tang) and crude saikosaponins inhibit hepatitis B virus in a stable HBV-producing cell line Am J Chin Med 35 2 2007 341 351
130. Y Li, RC Martin 2nd Herbal medicine and hepatocellular carcinoma: applications and challenges Evid Based Complement Alternat Med 2011 2011 541209
131. ZY Cao, XZ Chen, Y Lin, J Du Effect of Chinese compound prescription on expressions of c-kit and CD133 of tumor stem cell in mice of hepatocellular carcinoma transplanted subcutaneously Fujian Zhong Yi Xue Yuan Xue Bao 20 3 2010 18 21 Chinese with abstract in English.
132. ZY Cao, XZ Chen, LM Liao, J Peng, HX Hu, ZZ Liu, J Du Fuzheng Yiliu Granule inhibits the growth of hepatocellular cancer by regulating immune function and inducing apoptosis in vivo and in vitro Chin J Integr Med 17 9 2011 691 697
133. QT Gao, JK Cheung, RC Choi, AW Cheung, J Li, ZY Jiang, R Duan, KJ Zhao, AW Ding, TT Dong, KW Tsim A Chinese herbal decoction prepared from Radix Astragali and Radix Angelicae Sinensis induces the expression of erythropoietin in cultured Hep3B cells Planta Med 74 4 2008 392 395
134. S Wang, X Xu, W Zhang, A Li, W Dong Effects of Erbie San on Walker-256 liver cancer and adjustment to unbalance of VEGF/endostatin in rats Zhongguo Zhong Yao Za Zhi 34 1 2009 89 91 Chinese with abstract in English.
135. T Chen, D Li, YL Fu, W Hu Screening of QHF formula for effective ingredients from Chinese herbs and its anti-hepatic cell cancer effect in combination with chemotherapy Chin Med J (Engl) 121 4 2008 363 368
136. B Sun, J Meng, T Xiang, Z Chen, Y Li, L Lu, S Zhang, X Chen Jianpijiedu fang improves survival of hepatocarcinoma mice by affecting phosphatase and tensin homolog, phosphoinositide 3-kinase, and focal adhesion kinase J Tradit Chin Med 33 4 2013 479 485
137. LW Chen, J Lin, W Chen, W Zhang Effect of Chinese herbal medicine on patients with primary hepatic carcinoma in III stage during perioperational period: a report of 42 cases Zhongguo Zhong Xi Yi Jie He Za Zhi 25 9 2005 832 834 Chinese with abstract in English.
138. S Valastyan, RA Weinberg Tumor metastasis: molecular insights and evolving paradigms Cell 147 2 2011 275 292
139. X Liu, Y Yang, X Zhang, S Xu, S He, W Huang, MS Roberts Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-β/Smad in HepG2 cell J Gastroenterol Hepatol 25 2 2010 420 426
140. D Kershenobich Stalnikowitz, AB Weissbrod Liver fibrosis and inflammation: A review Ann Hepatol 2 4 2003 159 163
141. A Mantovani, P Allavena, A Sica, F Balkwill Cancer-related inflammation Nature 454 7203 2008 436 444
142. P Muriel NF-κB in liver diseases: a target for drug therapy J Appl Toxicol 29 2 2009 91 100
143. K Song, J Wu, C Jiang Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review) Oncol Rep 29 1 2013 3 12
144. GH Qiang, DC Yu, CP Jiang Side population cells and liver cancer stem cells Shi Jie Hua Ren Xiao Hua Za Zhi 18 10 2010 971 974 Chinese with abstract in English.
145. S Ma, KW Chan, L Hu, TK Lee, JY Wo, IO Ng, BJ Zheng, XY Guan Identification and characterization of tumorigenic liver cancer stem/progenitor cells Gastroenterology 132 7 2007 2542 2556
146. + HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway Oncogene 27 12 2008 1749 1758
147. W Song, H Li, K Tao, R Li, Z Song, Q Zhao, F Zhang, K Dou Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma Int J Clin Pract 62 8 2008 1212 1218
148. T Yamashita, M Forgues, W Wang, JW Kim, Q Ye, H Jia, A Budhu, KA Zanetti, Y Chen, LX Qin, ZY Tang, XW Wang EpCAM and α-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma Cancer Res 68 5 2008 1451 1461
149. T Yamashita, J Ji, A Budhu, M Forgues, W Yang, HY Wang, H Jia, Q Ye, LX Qin, E Wauthier, LM Reid, H Minato, M Honda, S Kaneko, ZY Tang, XW Wang EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features Gastroenterology 136 3 2009 1012 1024
150. + liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation Cell Stem Cell 9 1 2011 50 63
151. + cancer stem cells in human liver cancer Cancer Cell 13 2 2008 153 166
152. ZF Yang, P Ngai, DW Ho, WC Yu, MN Ng, CK Lau, ML Li, KH Tam, CT Lam, RT Poon, ST Fan Identification of local and circulating cancer stem cells in human liver cancer Hepatology 47 3 2008 919 928
153. AV Salnikov, G Kusumawidjaja, V Rausch, H Bruns, W Gross, A Khamidjanov, E Ryschich, MM Gebhard, G Moldenhauer, MW Büchler, P Schemmer, I Herr Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter Cancer Lett 275 2 2008 185 193
154. M Dean, Y Hamon, G Chimini The human ATP-binding cassette (ABC) transporter superfamily J Lipid Res 42 7 2001 1007 1017
155. S Chai, KK To, G Lin Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines Chin Med 5 2010 26
156. B Liu, T Wang, X Qian, G Liu, L Yu, Y Ding Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids Cancer Lett 268 1 2008 166 175
157. CH Choi, G Kang, YD Min Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng Planta Med 69 3 2003 235 240
158. HW Yao, XY Fu, QD Xie, BB Huang, YB Sun, GF Li Effect of liquorice decoction on rat intestinal P-glycoprotein Nan Fang Yi Ke Da Xue Xue Bao 29 8 2009 1571 1573 Chinese with abstract in English.
159. M Huang, J Jin, H Sun, GT Liu Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae Fructus Schizandrae 62 6 2008 1015 1026
160. LH Yu, GT Liu The structure-activity relationship of dibenzo (a, c) cyclooctene lignans isolated from Fructus schizandrae and innovation of novel anti-hepatitis drugs Hua Xue Jin Zhan 21 1 2009 66 76
161. WF Fong, CK Wan, GY Zhu, A Chattopadhyay, S Dey, Z Zhao, XL Shen Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes Planta Med 73 3 2007 212 220
162. ST Yu, TM Chen, JW Chern, SY Tseng, YH Chen Down-regulation of GSTpi expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis Anticancer Drugs 20 5 2009 382 388
163. T Efferth, M Davey, A Olbrich, G Rücker, E Gebhart, R Davey Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells Blood Cells Mol Dis 28 2 2002 160 168
164. L He, GQ Liu Effects of various principles from Chinese herbal medicine on rhodamine 123 accumulation in brain capillary endothelial cells Acta Pharmacol Sin 23 7 2002 591 596
165. H Satsu, Y Hiura, K Mochizuki, M Hamada, M Shimizu Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals J Agric Food Chem 56 13 2008 5366 5373
166. U Gödtel-Armbrust, A Metzger, U Kroll, O Kelber, L Wojnowski Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort Naunyn Schmiedebergs Arch Pharmacol 375 6 2007 377 382
167. R Nowack Cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: Grapefruit juice, St John's Wort-and beyond Nephrology (Carlton) 13 4 2008 337 347
168. DL Whitten, SP Myers, JA Hawrelak, H Wohlmuth The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials Br J Clin Pharmacol 62 5 2006 512 526
169. XW Ding, JH Wu, CP Jiang ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy Life Sci 86 17-18 2010 631 637
170. KD Bunting ABC transporters as phenotypic markers and functional regulators of stem cells Stem Cells 20 1 2002 11 20
171. S Zhou, JD Schuetz, KD Bunting, AM Colapietro, J Sampath, JJ Morris, I Lagutina, GC Grosveld, M Osawa, H Nakauchi, BP Sorrentino The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype Nat Med 7 9 2001 1028 1034
172. H Lou, M Dean Targeted therapy for cancer stem cells: the patched pathway and ABC transporters Oncogene 26 9 2007 1357 1360
173. M Dean, T Fojo, S Bates Tumor stem cells and drug resistance Nat Rev Cancer 5 4 2005 275 285
174. K Moitra, H Lou, M Dean Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development Clin Pharmacol Ther 89 4 2011 491 502
175. WB Liu, XB Tan, XB Jia, SM Yu Research approach on chemoprevention of Chinese materia medica via Nrf2 signal pathway Zhong Cao Yao 42 7 2011 1429 1434 Chinese.
176. JS Pan, MZ Hong, JL Ren Reactive oxygen species: a double-edged sword in oncogenesis World J Gastroenterol 15 14 2009 1702 1707
177. AK Maiti Genetic determinants of oxidative stress-mediated sensitization of drug-resistant cancer cells Int J Cancer 130 1 2012 1 9
178. KK Nelson, JA Melendez Mitochondrial redox control of matrix metalloproteinases Free Radic Biol Med 37 6 2004 768 784
179. L Li, Y Chen, SB Gibson Starvation-induced autophagy is regulated by mitochondrial reactive oxygen species leading to AMPK activation Cell Signal 25 1 2013 50 65
180. L Galluzzi, G Kroemer Necroptosis: a specialized pathway of programmed necrosis Cell 135 7 2008 1161 1163
181. JS Lee, YJ Surh Nrf2 as a novel molecular target for chemoprevention Cancer Lett 224 2 2005 171 184
182. SF Ye, ZQ Hou, LM Zhong, QQ Zhang Effect of curcumin on the induction of glutathione S-transferases and NADP(H): quinone oxidoreductase and its possible mechanism of action Yao Xue Xue Bao 42 4 2007 376 380
183. ST Dance-Barnes, ND Kock, JE Moore, EY Lin, LJ Mosley, RB D'Agostino Jr, TP McCoy, AJ Townsend, MS Miller Lung tumor promotion by curcumin Carcinogenesis 30 6 2009 1016 1023
184. XJ Qin, W He, CX Hai, X Liang, R Liu Protection of multiple antioxidants Chinese herbal medicine on the oxidative stress induced by adriamycin chemotherapy J Appl Toxicol 28 3 2008 271 282
185. P Gao, XW Tang, XJ Wang Nrf2 as a chemoprevention target in gastrointestinal carcinoma Zhejiang Da Xue Xue Bao Yi Xue Ban 41 4 2012 453 463 Chinese with abstract in English.
186. XJ Wang, JG Wu, XW Tang Down-regulation of Nrf2-ARE signaling pathway Zhejiang Da Xue Xue Bao Yi Xue Ban 39 1 2010 1 5 Chinese.
187. S Liu, H Zhang, C Gu, J Yin, Y He, J Xie, G Cao Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis J Natl Cancer Inst 101 15 2009 1066 1082
188. HL Chan, CH Tse, F Mo, J Koh, VW Wong, GL Wong, S Lam Chan, W Yeo, JJ Sung, TS Mok High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma J Clin Oncol 26 2 2008 177 182
189. Y Feng, KF Cheung, N Wang, P Liu, T Nagamatsu, Y Tong Chinese medicines as a resource for liver fibrosis treatment Chin Med 4 2009 16
190. HB El-Serag, KL Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 7 2007 2557 2576
191. JA Davila, RO Morgan, PA Richardson, XL Du, KA McGlynn, HB El-Serag Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States Hepatology 52 1 2010 132 141
192. GL Wong, VW Wong, PC Choi, AW Chan, AM Chim, KK Yiu, HY Chan, FK Chan, JJ Sung, HL Chan Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B Gut 58 1 2009 111 117
193. S Waxman, KC Anderson History of the development of arsenic derivatives in cancer therapy Oncologist 6 suppl 2 2001 3 10
194. A Emadi, SD Gore Arsenic trioxide - An old drug rediscovered Blood Rev 24 4-5 2010 191 199
195. Arsenious Acid and Sodium Chloride Injection. [2014-10-21] http://www.yidayaoye.com/show.asp?id=19 Chinese
196. LG Lu, MD Zeng, YM Mao, JQ Li, MB Wan, CZ Li, CW Chen, QC Fu, JY Wang, WM She, X Cai, J Ye, XQ Zhou, H Wang, SM Wu, MF Tang, JS Zhu, WX Chen, HQ Zhang Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial World J Gastroenterol 9 11 2003 2480 2483
197. BJ Veldt, BE Hansen, K Ikeda, E Verhey, H Suzuki, SW Schalm Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon Scand J Gastroenterol 41 9 2006 1087 1094
198. YH Liao, CC Lin, TC Li, JG Lin Utilization pattern of traditional Chinese medicine for liver cancer patients in Taiwan BMC Complement Altern Med 12 1 2012 146
199. CC Kuo, HL Hung Liver cirrhosis and hepatocellular carcinoma treated with traditional Chinese medicine - a case report Sci J Tradit Chin Med 3 1 2008 34 39
200. X Shu, M McCulloch, H Xiao, M Broffman, J Gao Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials Integr Cancer Ther 4 3 2005 219 229
201. YM Liu, H Qin, CB Wang, XH Fang, QY Ma Comparison of therapeutic effectiveness of combined interventional therapy for 1126 cases of primary liver cancer World J Gastroenterol 12 31 2006 5060 5063
202. National Cancer Institute Thinking about complementary and alternative medicine: A guide for people with cancer. (2005-08-06) [2014-09-21] http://www.cancer.gov/cancertopics/cam/thinking-about-CAM
203. WZ Li, RJ Feng Clinical effects of Yadanzi oil injection combined with TACE on primary liver cancer Zhong Yao Cai 29 6 2006 632 633 Chinese.
204. SY Ding, CJ Zhang, CH Zhang Studies on apoptosis of human hepatoma cell induced by Chansu injection Shi Yong Yi Yao Za Zhi 23 10 2006 1203 1205 Chinese with abstract in English.
205. Z Cui Therapeutic effect of Huachansu combined with chemotherapy on mice with orthotopic transplantation of hepatocellular carcinoma Hebei Yi Yao 32 18 2010 2489 2492 Chinese with abstract in English.
206. D Normile Asian medicine. The new face of traditional Chinese medicine Science 299 5604 2003 188 190
207. T Xue, R Roy Studying traditional Chinese medicine Science 300 5620 2003 740 741
208. L Xu, LX Lao, A Ge, S Yu, J Li, PJ Mansky Chinese herbal medicine for cancer pain Integr Cancer Ther 6 3 2007 208 234
209. JY Wang, L Xu, RX Zhang, L Lao Traditional Chinese medicine for cancer pain J Chin Integr Med 9 2 2011 129 134 Chinese with abstract in English.
210. S Basu, A Ganguly, P Chakraborty, R Sen, K Banerjee, M Chatterjee, T Efferth, SK Choudhuri Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff's base to overcome MDR in cancer Biochimie 94 1 2012 166 183
211. SS Yun, SP Kim, MY Kang, SH Nam Inhibitory effect of curcumin on liver injury in a murine model of endotoxemic shock Biotechnol Lett 32 2 2010 209 214
212. CQ Ling, XQ Yue, C Ling Three advantages of using traditional Chinese medicine to prevent and treat tumor J Integr Med 12 4 2014 331 335
213. F Cheung, X Wang, N Wang, MF Yuen, TC Ziea, Y Tong, VT Wong, Y Feng Chinese medicines as an adjuvant therapy for unresectable hepatocellular carcinoma during transarterial chemoembolization: A meta-analysis of randomized controlled trials Evid Based Complement Alternat Med 2013 2013 487919
214. Y Feng, N Wang The new generation of drug discovery and its analytical technologies Bioequival Bioavail 5 2013 e42
215. N Wang, M Zhu, X Wang, HY Tan, SW Tsao, Y Feng Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma Biochim Biophys Acta 1839 9 2014 849 857
216. CM Tsang, KC Cheung, YC Cheung, K Man, VW Lui, SW Tsao, Y Feng Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma Biochim Biophys Acta 1852 3 2015 541 551
217. HY Tan, N Wang, SW Tsao, Z Zhang, Y Feng Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2 by alkaloids in Coptidis rhizome in hepatocellular carcinoma Integr Cancer Ther 13 5 2014 425 434